Table 5.
n | PH | PS | SO | SE | |
---|---|---|---|---|---|
RT stages | |||||
Before RT | 60 | 65.9 ± 15.5 | 54.5 ± 15.8 | 60.8 ± 17.6 | 71.6 ± 17.0 |
During RT | 171 | 54.0 ± 14.9 | 47.4 ± 13.6 | 58.3 ± 15.7 | 59.2 ± 17.9 |
≤1 year after RT | 145 | 59.3 ± 14.2 | 48.5 ± 16.5 | 57.5 ± 15.6 | 62.6 ± 16.3 |
~5 years after RT | 65 | 63.5 ± 14.1 | 55.1 ± 16.3 | 63.8 ± 17.6 | 70.5 ± 15.9 |
>5 years after RT | 46 | 72.3 ± 17.4 | 54.3 ± 14.7 | 61.3 ± 24.2 | 73.0 ± 15.4 |
P-value | <0.001 | <0.001 | 0.100 | <0.001 | |
RT method | |||||
IMRT | 294 | 61.3 ± 15.7 | 51.5 ± 15.2 | 61.8 ± 16.4 | 66.8 ± 16.7 |
Three-dimensional RT | 46 | 56.8 ± 13.2 | 44.5 ± 14.1 | 56.7 ± 17.1 | 60.6 ± 17.5 |
Conventional RT | 86 | 53.4 ± 16.1 | 46.3 ± 15.6 | 51.8 ± 17.7 | 53.9 ± 16.6 |
No RT | 60 | 65.9 ± 15.5 | 54.5 ± 15.8 | 60.8 ± 17.6 | 71.6 ± 17.0 |
P-value | <0.001 | <0.001 | <0.001 | <0.001 |
RT radiotherapy, IMRT intensity-modulated radiotherapy